Protein Corona Attenuates the Targeting of Antitumor Sialyl Lewis X-Decorated Liposomes to Vascular Endothelial Cells under Flow Conditions.

Sialyl Lewis X endothelial cells lipophilic prodrug melphalan microfluidics nanosized liposomes proteome

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
16 Jun 2023
Historique:
received: 17 04 2023
revised: 23 05 2023
accepted: 12 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Previously, we showed in the human umbilical vein endothelial cells (HUVECs) model that a liposome formulation of melphalan lipophilic prodrug (MlphDG) decorated with selectin ligand tetrasaccharide Sialyl Lewis X (SiaLe

Identifiants

pubmed: 37376203
pii: pharmaceutics15061754
doi: 10.3390/pharmaceutics15061754
pmc: PMC10303272
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Russian Science Foundation
ID : 21-74-20177
Organisme : Russian Foundation for Basic Research
ID : 19-015-00499

Références

Chem Soc Rev. 2012 Apr 7;41(7):2780-99
pubmed: 22086677
Langmuir. 2019 Feb 5;35(5):1273-1283
pubmed: 29933695
J Lipid Res. 2007 Jul;48(7):1518-1532
pubmed: 17416929
ACS Appl Mater Interfaces. 2013 Dec 26;5(24):13171-9
pubmed: 24245615
Thromb Res. 2010 Feb;125(2):e33-9
pubmed: 19878975
Colloids Surf B Biointerfaces. 2017 May 1;153:263-271
pubmed: 28273493
J Drug Target. 2014 Oct 7;22(3):242-250
pubmed: 24313904
Bionanoscience. 2022;12(1):274-291
pubmed: 35096502
Vasc Endovascular Surg. 2003 Jan-Feb;37(1):47-57
pubmed: 12577139
Hellenic J Cardiol. 2005 Jan-Feb;46(1):9-15
pubmed: 15807389
Kidney Int Suppl. 1998 Sep;67:S100-8
pubmed: 9736263
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
Colloids Surf B Biointerfaces. 2018 Jun 1;166:45-53
pubmed: 29533843
Mol Pharm. 2017 Dec 4;14(12):4618-4627
pubmed: 29096441
Biochim Biophys Acta. 2006 Nov;1764(11):1757-66
pubmed: 17055788
Pharmaceuticals (Basel). 2021 Mar 26;14(4):
pubmed: 33810483
Biochim Biophys Acta. 2015 May;1848(5):1099-110
pubmed: 25646577
Adv Drug Deliv Rev. 2004 Mar 3;56(4):527-49
pubmed: 14969757
Adv Drug Deliv Rev. 2011 Mar 18;63(3):136-51
pubmed: 20441782
J Control Release. 2012 Mar 10;158(2):194-206
pubmed: 21983284
Pharmaceutics. 2019 Aug 03;11(8):
pubmed: 31382634
Mol Immunol. 2011 Aug;48(14):1611-20
pubmed: 21529951
Cell Tissue Res. 2009 Jan;335(1):283-300
pubmed: 18815813
Biophys J. 2007 Feb 1;92(3):787-97
pubmed: 17085490
Immunol Rev. 2001 Apr;180:35-48
pubmed: 11414361
Circ Res. 1978 Nov;43(5):738-49
pubmed: 709740
J Control Release. 2022 Nov;351:22-36
pubmed: 36087801
Trends Cell Biol. 2007 Jan;17(1):44-50
pubmed: 17141502
J Thromb Haemost. 2011 Jul;9(7):1275-84
pubmed: 21535391
Nanoscale. 2015 Sep 7;7(33):13958-66
pubmed: 26222625
J Membr Biol. 2003 Mar 1;192(1):33-43
pubmed: 12647032
J Drug Target. 2020 Apr;28(4):379-385
pubmed: 31822133
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949-53
pubmed: 3413128
Electrophoresis. 2000 Jan;21(1):27-40
pubmed: 10634468
Res Pract Thromb Haemost. 2019 Dec 29;4(2):217-223
pubmed: 32110751
Expert Opin Ther Targets. 2007 Nov;11(11):1473-91
pubmed: 18028011
Russ J Immunol. 2002 Jul;7(2):115-22
pubmed: 12687253
Bioeng Transl Med. 2017 Mar;2(1):109-119
pubmed: 28713860
Adv Drug Deliv Rev. 2020;154-155:163-175
pubmed: 32745496
ACS Nano. 2017 Jan 24;11(1):12-18
pubmed: 28068099
PLoS One. 2015 Sep 25;10(9):e0138775
pubmed: 26407052
Mol Pharm. 2016 Aug 1;13(8):2603-4
pubmed: 27404330
Pharmaceutics. 2017 Mar 27;9(2):
pubmed: 28346375
Pharmaceutics. 2021 Jul 06;13(7):
pubmed: 34371717
Glycoconj J. 2020 Apr;37(2):277-291
pubmed: 32062824
J Phys Chem B. 2014 Dec 11;118(49):14017-26
pubmed: 24779411
Biomacromolecules. 2018 Jul 9;19(7):2580-2594
pubmed: 29668268
RSC Adv. 2019 Jul 2;9(36):20518-20527
pubmed: 35515515
Front Biosci (Landmark Ed). 2011 Jun 01;16(9):3233-51
pubmed: 21622232
PLoS One. 2020 Jan 16;15(1):e0221915
pubmed: 31945064
Lab Chip. 2019 Aug 7;19(15):2557-2567
pubmed: 31243412
J Clin Invest. 1973 Nov;52(11):2745-56
pubmed: 4355998
J Clin Invest. 2016 Mar 1;126(3):821-8
pubmed: 26928035
Clin Cancer Res. 2012 Jan 15;18(2):454-64
pubmed: 22065082
Nanomedicine (Lond). 2020 Feb;15(3):303-318
pubmed: 31802702
Int J Pharm. 2018 Sep 15;548(2):759-770
pubmed: 29038064
ACS Chem Neurosci. 2018 Dec 19;9(12):3166-3174
pubmed: 30015470
Mol Pharm. 2017 May 1;14(5):1528-1537
pubmed: 28191842
Front Biosci (Elite Ed). 2018 Jan 1;10(1):74-91
pubmed: 28930605
J Drug Target. 2017 Nov - Dec;25(9-10):786-795
pubmed: 28665212
Biomicrofluidics. 2015 Jun 30;9(5):052605
pubmed: 26180575
Int J Mol Sci. 2022 Jan 18;23(3):
pubmed: 35162957
Acc Chem Res. 2012 Mar 20;45(3):317-26
pubmed: 22074988
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Langmuir. 2015 Oct 6;31(39):10764-73
pubmed: 26378619
Br J Cancer. 2013 Feb 19;108(3):479-85
pubmed: 23299535
J Cell Biol. 1992 May;117(4):895-902
pubmed: 1374413
Colloids Surf B Biointerfaces. 2021 Jan;197:111421
pubmed: 33130525
Curr Drug Deliv. 2020;17(4):312-323
pubmed: 32056524
Pharmaceutics. 2021 Apr 01;13(4):
pubmed: 33915726
Angew Chem Int Ed Engl. 2020 Jul 27;59(31):12584-12588
pubmed: 32347625
Mol Pharm. 2016 Nov 7;13(11):3712-3723
pubmed: 27654150
Biochim Biophys Acta. 2002 Feb 10;1559(1):79-86
pubmed: 11825590
Biochim Biophys Acta. 2007 Jun;1768(6):1367-77
pubmed: 17400180
J Cell Biol. 2004 Sep 13;166(6):913-23
pubmed: 15364963
J Biol Chem. 2005 Nov 11;280(45):38108-16
pubmed: 16159884
Acta Biomater. 2021 Aug;130:460-472
pubmed: 34116227
Nat Commun. 2019 Aug 8;10(1):3561
pubmed: 31395892
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110760
pubmed: 32279783
Adv Healthc Mater. 2021 Jul;10(14):e2100370
pubmed: 34050634
Nanomedicine. 2019 Jun;18:135-145
pubmed: 30849548
Immunol Lett. 2016 Jan;169:82-92
pubmed: 26658464
Acta Biomater. 2021 Oct 15;134:57-78
pubmed: 34364016
Adv Drug Deliv Rev. 2013 Jan;65(1):36-48
pubmed: 23036225
Nanoscale. 2016 Jul 7;8(25):12755-63
pubmed: 27279572
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52):
pubmed: 34933999
J Control Release. 2012 Jun 10;160(2):394-400
pubmed: 22210161
Adv Drug Deliv Rev. 2017 Sep 15;119:44-60
pubmed: 28697952

Auteurs

Natalia R Onishchenko (NR)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Alexey A Moskovtsev (AA)

Institute of General Pathology and Pathophysiology, Russian Academy of Sciences, ul. Baltiyskaya 8, 125315 Moscow, Russia.

Maria K Kobanenko (MK)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Daria S Tretiakova (DS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Anna S Alekseeva (AS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Dmitry V Kolesov (DV)

Institute of General Pathology and Pathophysiology, Russian Academy of Sciences, ul. Baltiyskaya 8, 125315 Moscow, Russia.

Anna A Mikryukova (AA)

Institute of General Pathology and Pathophysiology, Russian Academy of Sciences, ul. Baltiyskaya 8, 125315 Moscow, Russia.

Ivan A Boldyrev (IA)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Marina R Kapkaeva (MR)

N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Healthcare of the Russian Federation, ul. Gamaleya 18, 123098 Moscow, Russia.

Olga N Shcheglovitova (ON)

N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Healthcare of the Russian Federation, ul. Gamaleya 18, 123098 Moscow, Russia.

Nicolai V Bovin (NV)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Aslan A Kubatiev (AA)

Institute of General Pathology and Pathophysiology, Russian Academy of Sciences, ul. Baltiyskaya 8, 125315 Moscow, Russia.

Olga V Tikhonova (OV)

Institute of Biomedical Chemistry, ul. Pogodinskaya 10, 119121 Moscow, Russia.

Elena L Vodovozova (EL)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.

Classifications MeSH